ChatAbout Dr. Bulent Karagoz
- Dr. Bulent Karagoz is a renowned Medical Oncologist with experience of over 20 years.
- His area of specialization covers Tumour Biology, Tumour Immunology, Immunotherapy of Cancer, and Targeted Therapies, etc.
- He is a member of the Turkish Medical Oncology Association.
- He is actively involved in research and has numerous publications to his credit in National and International journals.
- He completed Graduation from Gülhane Military Medical Academy, Faculty of Medicine, Istanbul in 1992. Thereafter, he did Postgraduation in Internal Medicine from GATA Haydarpaşa Training Hospital, in 1999. Then he did Medical Oncology Minor Training from GATA Haydarpaşa Training Hospital, in 2006. He also did the following courses: tumor Biology Course, Association of Medical Oncology, 2003, Applied Flow Cytometry Training, Istanbul University (DETAE), 2004, Basic Epidemiology (Research Methods and Analysis Techniques in Health) Course, GATA Command, 2005 and Ethical Approach in Clinical Research Course, Ministry of Health General Directorate of Pharmaceuticals and Pharmacy, 2009 and 2017 (twice)
Hospital
Location
LocationIstanbul, Turkey
Special Interest
Tumour Biology Tumour Immunology Immunotherapy of Cancer Targeted Therapies
List Of Treatments
- Metastatic Tumors Treatment
- Chemotherapy
- Radiotherapy
- Adrenal Cancer Treatment
- Anal Cancer Treatment
- Bile Duct Cancer Treatment
- Bladder Cancer Treatment
- Bone Cancer Treatment
- Breast Cancer-Surgical
- Cancer in Children
- Carcinoma of Unknown Primary (CUP) Treatment
- Castleman Disease Treatment
- Cervical Cancer Treatment
- Endometrial Cancer Treatment
- Esophagus Cancer Treatment
- Ewing Family of Tumors Treatment
- Eye Cancer Treatment
- Gallbladder Cancer Treatment
- Carcinoid Tumors Treatment
- Gastrointestinal Stromal Tumor GIST Treatment
- Gestational Trophoblastic Disease (GTD) Treatment
- Hodgkin Disease Treatment
- Kaposi Sarcoma Treatment
- Kidney Cancer Treatment
- Laryngeal and Hypopharyngeal Cancer Treatment
- Acute Lymphocytic Leukemia - ALL in Adults
- Leukemia - Acute Myeloid AML
- Chronic Lymphocytic Leukemia - CLL
- Chronic Myeloid Leukemia- CML
- Chronic Myelomonocytic Leukemia - CMML
- Leukemia in Children
- Liver Cancer
- Lung Cancer Treatment
- Non-Small Cell Lung Cancer (NSCLC) Treatment
- Small-cell Carcinoma Treatment
- Lung Carcinoid Tumor Treatment
- Skin Lymphoma Treatment
- Malignant Mesothelioma Treatment
- Multiple Myeloma Treatment
- Nasal Cavity and Paranasal Sinus Cancer Treatment
- Nasopharyngeal Cancer Treatment
- Neuroblastoma
- Non-Hodgkin Lymphoma (NHL) Treatment
- Non-Hodgkin Lymphoma In Children
- Oral Cavity and Oropharyngeal Cancer
- Osteosarcoma (OS) Treatment
- Ovarian Cancer Surgery
- Pancreatic Cancer
- Penile Cancer Treatment
- Prostate Cancer-Surgical
- Retinoblastoma (RB) Treatment
- Rhabdomyosarcoma (RMS) Treatment
- Salivary Gland Cancer
- Soft Tissue Sarcoma Treatment
- Skin Cancer
- Basal Cell and Squamous Cell Carcinoma
- Skin Cancer - Melanoma
- Small Intestine Cancer Treatment
- Stomach Cancer Treatment
- Testicular Cancer Treatment
- Thymoma and Thymic Carcinoma Treatment
- Thyroid Cancer Treatment
- Uterine Sarcoma
- Vaginal Cancer Treatment
- Vulvar Cancer Treatment
- Waldenstrom Macroglobulinemia
- Wilms Tumor (Nephroblastoma)
- Breast Biopsy
- Autologous Stem Cell Transplant for Lymphoma
- Pediatric Bone Marrow Transplant
- Oral Cancer - Surgical
- Breast Cancer
- Leukemia Treatment
- Hairy Cell Leukemia - HCL
- Fallopian Tube Cancer
- Ovarian Germ Cell Tumor
- Ovarian Primary Peritoneal Cancer
- Medullary Carcinoma
- Papillary Thyroid Cancer Treatment
- Bone Marrow Cancer
- Ovarian Sex Cord Stromal Tumor
- Invasive Lobular Carcinoma
- Colon Cancer Treatment
- Cancer Treatment
- Adenocarcinoma - Glandular Cancer Treatment
- Immunotherapy
- Breast Conservation Surgery - BCS
- Breast Lumpectomy
- IMRT
Work Experience of Dr. Bulent Karagoz
, Served, Turkish Cypriot Peace Forces Command
, Internal Medicine Specialist, Çorlu Soldier Hospital
, Served, NATO KFOR Command in NATO
, Assistant Professor
, Associate Professor
, Chief of Medical Oncology, Department of Internal Medicine, Department of GATA Haydarpaşa Training Hospital
, Professor, Istanbul Okan University Faculty of Medicine
, Head of Internal Diseases Department, Head of Internal Diseases and Medical Oncology Departments and Head of Medical Ethics Committee, Istanbul Okan University Faculty of Medicine
Senior Consultant, Anadolu Medical Center, Kocaeli, Istanbul
Dr. Bulent Karagoz's
- Graduation, 1992, Gülhane Military Medical Academy, Faculty of Medicine
- Post Graduation, 1999, Internal Medicine, GATA Haydarpaşa Training Hospital, Internal Medicine Specialist Training
- Post Graduation, 2006, Medical Oncology, GATA Haydarpaşa Training Hospital, Medical Oncology Minor Training
- , 2003, Tumor Biology Course, Association of Medical Oncology
- , 2004, Applied Flow Cytometry Training, Istanbul University (DETAE)
- , 2005, Basic Epidemiology (Research Methods and Analysis Techniques in Health) Course, GATA Command
- , Ethical Approach in Clinical Research Course, Ministry of Health General Directorate of Pharmaceuticals and Pharmacy, 2009 and 2017 (twice)
- Associated with research and has several publications to his credit in National and International journals. These are: Kandemir, EG, A. Mayadagli, B. Karagoz, O. Bilgi, O. Turken and M. Yaylaci, “Prognostic Significance of Thrombocytosis in Node-negative Colon Cancer, Int J Int Med Res, 33 (2), 228-235 (2005).
- Karagöz, B., S. Süleymanoğlu, G. Uzun, O. Bilgi, S. Aydınöz, A. Haholu, O. Türken, Y. Importance and EG Kandemir, “Hyperbaric Oxygen Therapy Does Not Potentiate Doxorubicin-induced Cardio toxicity in Rats, Basic Clin Pharmacol Toxicol, 102 (3), 287-292 (2008).
- Knowledge, O., B. Karagöz, O. Turken, EG Kandemir, A. Ozturk, M. Gumus and M. Yaylaci, “Peripheral Blood Gamma-Delta T Cells in Advanced Stage Cancer Patients,” Adv Ther, 25 (3) ), 218-224 (2008).
- Erikci, AA, A. Ozturk, B. Karagoz, O. Bilgi, O. Turken, C. Top and EG Kandemir, “Results of Combination Therapy with Amifostine, Pentoxifylline, Ciprofloxacin and Dexamethasone in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukaemia, Haematology, 13 (5), 289-292 (2008)
- Aydinoz, S., G. Uzun, H. Cermik, EM Atasoyu, Ş. Yildiz, B. Karagoz and R. Evrenkaya, “Effect of Different Doses of Hyperbaric Oxygen on Cisplatin-Induced Nephro-toxicity,” Ren Fail, 29 (3), 1-7 (2007).
- Erikci, AA, B. Karagoz, A. Ozturk, S. Caglayan, G. Ozisik, i. Kaygusuz and M. Ozata, "The Effect of Subclinical Hypothyroidism on Platelet Parameters," Haematology, 14 (2), 115-117 (2009).
- Karagoz, B., O. Information, M. Gumus, AA Erikci, Ö. Sayan, O. Turken, EG Kandemir, A. Ozturk and M. Yaylaci, “CD8 + CD28- Cells and CD4 + CD25 + Regulatory T cells in The Peripheral Blood of Advanced Stage Lung Cancer Patients,” Med Oncol, 27 (1), 29-33 (2010).
- Erikci, AA, B. Karagoz, M. Ozyurt, A. Ozturk, S. Kilic and O. Bilgi, “HLA-G Expression in B Chronic Lymphocytic Leukaemia: A New Prognostic Marker?” Haematology, 14 (2), 101- 105 (2009)
- Karagöz, B., O. Information, EG Kandemir, Ö. Sayan, AA Erikci, A. Ozgun, B. Yilmaz and A. Ozturk, “Decreased NKG2D Expression on Natural Killer Cells in Gastric Cancer Patients”, UHOD, 19 (1), 42-47 (2009).
- Karagöz, B., O. Bilgi, A. Alacacıoğlu, A. Özgün, Ö Sayan, AA Erikçi and EG Kandemir, “Mean Platelet Volume Increase after Tamoxifen, but not after Anastrazole in Adjuvant Therapy of Breast Cancer,” Med Oncol, 27 (2), 199-202 (2010).
- Karagoz, B., O. Information, EG Kandemir, AA Erikci, Ö. Sayan, Ö. Alpaslan, B. Yilmaz, O. Turken, A. Alacacioglu, A. Ozturk, “CD4 + CRTH2 + Cells in Advanced Stage Non Small Cell Lung Cancer,” Central European Journal of Medicine, 5: 431 (2010)
- Karagöz, B., İ. Sücüllü, Ö. Sayan, O. Bilgi, T. Tuncel, A. İ. Filiz, E. Yucel, A. Ozgun, AA Erikci, A. Alacacioglu and EG Kandemir, “Platelet indices in patients with colorectal cancer”, Central European Journal of Medicine, 5: 365 (2010).
- Özgün, A., B. Karagöz, O. Bilgi, EG Kandemir and O. Türken, “The Prognostic Significance of Co-morbidity and Relation of Co-morbidity with Patients with Non-Small Cell Lung Cancer U, UHOD, 19 (2) ), 63-68 (2009).
- Cetinkaya H, Karagoz B, Information O, Ozgun A, Tuncel T, Emirzeoglu L, Top C, Kandemir EG. Nesfatin-1 in advanced lung cancer patients with weight loss, Regulatory Peptides 2013; 181: 1-3.
- Ozgun A, Karagoz B, Bilgi O, Tuncel T, Baloglu H, Kandemir EG MicroRNA-21 as an Indicator of Aggressive Phenotype in Breast Cancer. Onkologie 2013; 36: 115-118.
- Tuncel, T., B. Karagoz, A. Haholu, A. Ozgun, L. Emirzeoglu, and O. Bilgi and EG Kandemir, “Immuno-regulatory Function of HLA-G in Gastric Cancer, Asian Pac J Cancer Prev. 2013; 14 (12): 7681-4.
- Ozgun A., B. Karagoz, T. Tuncel, L. Emirzeoglu, S. Celik and O. Bilgi, “Clinicopathological features and survival of young Turkish patients with testicular germ cell tumours.” Asian Pac J Cancer Prev. 2013; 14 (11): 6889-92.
- Haholu A., U. Berber, B. Karagoz, T. Tuncel, O. Bilgi and D. Demirel, “There is no association of glutathione S-transferase T1 (GSTT1) and glutathione S-transferase M1 (GSTM1) gene polymorphism with gastric cancers? ” Pol J Pathol, 2013; 64 (4): 247-52.
- Karagoz B., A. Haholu, A. Ozgun, O. Bilgi, T. Tuncel, L. Emirzeoglu, S. Celik and D. Demirel. “HLA-G in Testicular Germ Cell Tumors,” Oncol Res Treat, 2014; 37: 245–248
- Information O., B. Karagoz, O. Turken, M. Gultepe, A. Ozgun, T. Tuncel, L. Emirzeoglu, S. Celik, T. Muftuoglu and EG. Kandemir, “CD4 + CD25high, CD8 + CD28– cells and thyroid auto-antibodies in breast cancer patients,” Central Eur J Immun 2014; 39 (3): 338-344.
- Tuncel T, Ozgun A, Emirzeoglu L, Celik S, Bilgi O and Karagoz B. “Mean platelet volume as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab-combined chemotherapy.” Asian Pac J Cancer Prev. 15 (15): 6421-3 (2014)
- Adayener, C., İ. Akyol, B. Sen, F. Ates, A. Haholu, H. Soydan and B. Karagoz, “Sertoli Cell Tumor of the Testis: A Case with Late Metastasis,” Int Urol Nephrol, 40 (4), 1005-1008 (2008).
- Karagöz, B., O. Information, İ. Akyol, A. Ozgun, O. Turken and EG Kandemir, “Cerebrovascular Accident after Chemotherapy for Testicular Cancer,” Mil Med, 174 (3), 320-321 (2009).
- Karagoz, B., A. Ayata, O. Bilgi, G. Uzun, M. Unal, EG Kandemir, A. Ozgun, O. Turken, “Hemi central Retinal Artery Occlusion in a Breast Cancer Patient Using Anastrazole,” Onkologie, 32 (7), 421-423 (2009)
- Turken, O., C. Basekim, A. Haholu, B. Karagoz, O. Bilgi, A. Ozgun, Y. Kucukardali, Y. Narin, Y. Yazgan and EG Kandemir, “Hyper-ammonemic Encephalopathy in a Patient with Primary Hepatic Neuro-endocrine Carcinoma, ”Med Oncol. 26 (3), 309-313 (2009)
- Erikci, AA, Ö. Sayan, B. Karagöz, Z. Büyükodacı, and M. Velioğlu, “Intracerebral Plasma-cytoma as an Initial Presentation of Multiple Myeloma”, Central European Journal of Medicine, DOI: 10.2478 / s11536-009-0104-8 [Electronic Edition] (2009) ).
- Karagöz, B., O. Bilgi, A. Özgün, A. Alacacıoğlu, B. Yılmaz and EG Kandemir, “Autoimmunity and Thyroid Dysfunction during Sunitinib Treatment in Metastatic Renal Cell Carcinoma”, Endocrinologist, 19 (5), 224-225 (2009)
- Information, O., B. Karagöz, H. Çermik, O. Türken and EG Kandemir, "A Case of Neck Metastasis in Early Stage of Gastric Carcinoma", UHOD, 20 (2), 119-121 (2010)
- Filiz, A. İ., İ. Sücüllü, Y. Kurt, O. School, Z. Küçük Küçükdadacı, and B. Karagöz, “Seminoma presented with acute abdomen due to ileum perforation”, Centre l European Journal of Medicine, DOI: 10.2478 / s11536-009-0128-0 (2009) ).
- Caliskan T, A. Ozgun, E. Demirer, A. Haholu, B. Karagoz and Farmer F. Aggressive and HIV-negative HHV8-unrelated Primary Effusion-like Lymphoma with T-cell phenotype: A Rare Case Report. Acta Medica Mediterranean, 30, 127-130 (2014)
- Ozgun A, Tuncel T, Emirzeoglu L, Celik S, Bilgi O, Haholu A, Urhan M, Karagoz B. Malignant melanoma and papillary thyroid carcinoma that were diagnosed concurrently and were treated simultaneously: A rare case report and review of the literature. Oncology Letters 2014
- Tuncel T, Ozgun A, Emirzeoglu L, Celik S, Bilgi O, Karagoz B. Broca's Aphasia: Case report and review of the literature. Oncology Letters, 2014
- Akyol AE, Karagöz B, Bilgi O. Regulatory T cells in patients with Idiopathic Thrombocytopenic Purpura. Turk J Hematol 2016; 33: 153-155
- Turken, O., B. Karagöz, O. Bilgi, B. Doğan, EG Kandemir and E. Kunter, “Oral Etoposide-Induced Leucocytoclastic Vasculitis in a Patient with Lung Carcinoma,” J Eur Acad Dermatol Venereol, 21 (9), 1297-1298 (2007).
- Atasoyu, EM, O. Bigi, RC Kinalp, B. Karagoz, A. Haholu, S. Unver and TR Evrenkaya, “Cutaneous Kaposi's Sarcoma Fallowing Immunosuppressive Therapy for Membranoproliferative Glomerulonephritis”, Clinical Nephrology, 72 (5), 420-421 ( 2009).
- Information, O., B. Karagöz, A. Alacacıoğlu, A. Özgün, T. Tuncel and EG Kandemir, “Irinotecan and cisplatin vs. cyclophosphamide, doxorubicin, and vincristine as second line treatment after platinum and Etoposide in small cell lung cancer”, J BUON, 15 (2), 395 (2010).
- Ozgun A, Tuncel T, Emirzeoglu L, Bilgi O, Karagoz B. Epidemiological characteristics of patients who died of cancer in Haydarpaşa Training Hospital, Istanbul. Croatian Medical Journal 2012; 53 (6): 645.
- Karagoz B. and Bilgi O, Systemic Treatment in Ductal Carcinoma in situ, The Journal of Breast Health 2013; 9: 44-7.
- Erikci, AA, A. Ozturk, Ö. Sayan, O. Bilgi and B. Karagoz, “Acute lymphoblastic leukemia presented with priapism”, Balkan Military Medical Review, 11, 146-147 (2008)
- Information O, Karagoz B, Alacacioglu A, Tuncel T, Ozgun A, Emirzeoglu L, Kandemir EG. The effect of Cisplatin-Etoposide Chemotherapy on platelet parameters in lung cancer patients Disease and Molecular Medicine 2013; 1 (2): 35-38.
- Karagoz B. and O. Information, Individualized Systemic Treatment of Lung Cancer. Disease and Molecular Medicine 2013; 1 (1): 15-18.
- Karagöz B, Bilgi O, Özgün A, Emirzeoğlu L, Çelik S and Abstract A. '' Long term survival with the combination of interferon and chemotherapy in metastatic melanoma '' J Egypt Natl Canc Inst. 27 (3): 2015: 61-3.
- Karagöz B, Özgün A, Emirzeoğlu L, Tuncel T, Çelik S, Bilgi O and Kara K. “Long-term survival after Lapatinib Rechallenge in Isolated Brain Metastasis of HER2-positive Breast Cancer” J Breast Health 2015; 11: 48-51.
Wondering where to start?
(Get Free opinion, Quote, Medical Visa Invitation and Assistance at every step of your treatment.)
Doctor Similar to Dr. Bulent Karagoz in Istanbul
Prof. Dr. Savaş Tuna
Medical Oncologist
Professor
Graduation
Istanbul, Turkey
30 years of experience
Medical Park Group, Istanbul
Dr. Nil Molinas Mandel
Medical Oncologist
Professor
Istanbul, Turkey
24 years of experience
American Hospital, Istanbul
Dr. Mustafa Ozdogan
Medical Oncologist
Consultant
MBBS
Istanbul, Turkey
15 years of experience
Memorial Hospitals Group, İstanbul
Assoc. Dr. Fatih Selçukbiricik
Medical Oncologist
Associate Professor
Istanbul, Turkey
years of experience
KOC University Hospital, Istanbul
Dr. Mustafa Yaylaci
Medical Oncologist
Consultant
Graduation,Post Graduation
Istanbul, Turkey
14 years of experience
Kolan International Hospital, Istanbul
Dr. Ahmet Bilici
Medical Oncologist
Senior Consultant
MBBS
Istanbul, Turkey
25 years of experience
Medipol University Hospital, İstanbul
Dr. Ali Zirh
Medical Oncologist
Senior Consultant
MBBS
Istanbul, Turkey
25 years of experience
Medipol University Hospital, İstanbul
Prof. Tolga Tasci
Medical Oncologist
Consultant
MBBS,MCh,MS
Istanbul, Turkey
17 years of experience
V M Medical Park, Pendik
Dr. Nedret Taflan Salepci
Medical Oncologist
Professor
Fellowship,Graduation,Post Graduation
Istanbul, Turkey
35 years of experience
Yeni Yuzyil University Gaziosmanpasa Hospital, Istanbul
Prof. Emin Gökhan KANDEMİR
Medical Oncologist
Professor
Istanbul, Turkey
41 years of experience
Memorial Hospitals Group, İstanbul
Dr. Okhan Kuzhan
Medical Oncologist
Consultant
Graduation,Post Graduation
Istanbul, Turkey
27 years of experience
Yeditepe University Healthcare Institutions, Istanbul
Dr. Ibrahim Tek
Medical Oncologist
Consultant
Graduation,Post Graduation
Istanbul, Turkey
24 years of experience
Medicana International Istanbul
DR. ABDULLAH BÜYÜKÇELİK
Medical Oncologist
Senior Consultant
Istanbul, Turkey
23 years of experience
Acibadem Hospitals Group
Dr. Burcak Erkol
Medical Oncologist
Consultant
Fellowship,MBBS,MD
Istanbul, Turkey
23 years of experience
Yeditepe University Healthcare Institutions, Istanbul
Dr. N. Serdar Turhal
Medical Oncologist
Senior Consultant
Graduation,Post Graduation
Istanbul, Turkey
22 years of experience
Anadolu Medical Center, Kocaeli, Istanbul
Dr. Mustafa Öncel
Medical Oncologist
Professor
Graduation
Istanbul, Turkey
21 years of experience
Medipol University Hospital, İstanbul
Dr. Kerim Kaban
Medical Oncologist
Consultant
Fellowship,Graduation,Post Graduation
Istanbul, Turkey
21 years of experience
American Hospital, Istanbul
Dr. Ali Arican
Medical Oncologist
Senior Consultant
Istanbul, Turkey
21 years of experience
Acibadem Hospitals Group
Prof. A.Uğur Yılmaz M.D.
Medical Oncologist
Professor
Graduation
Istanbul, Turkey
20 years of experience
Medical Park Group, Istanbul
Dr. Seref Kömürcü
Medical Oncologist
Senior Consultant
Graduation,Post Graduation
Istanbul, Turkey
20 years of experience
Anadolu Medical Center, Kocaeli, Istanbul
Dr. Bala Basak Oven
Medical Oncologist
Professor
MBBS,MD
Istanbul, Turkey
20 years of experience
Yeditepe University Healthcare Institutions, Istanbul
Assoc. Prof. Sadi Kerem OKUTUR
Medical Oncologist
Associate Professor
Istanbul, Turkey
19 years of experience
Memorial Hospitals Group, İstanbul
Dr. Omer Fatih Olmez
Medical Oncologist
Associate Professor
Graduation
Istanbul, Turkey
18 years of experience
Medipol University Hospital, İstanbul
Prof. Dr. Taner Korkmaz
Medical Oncologist
Professor
Graduation,Post Graduation
Istanbul, Turkey
17 years of experience
Acibadem Hospitals Group
Assoc. Prof. Kübra AYDIN
Medical Oncologist
Associate Professor
Istanbul, Turkey
16 years of experience
Memorial Hospitals Group, İstanbul
DR. MERAL GUNALDI
Medical Oncologist
Associate Consultant
Graduation,Post Graduation
Istanbul, Turkey
16 years of experience
Medical Park Group, Istanbul
Prof. Cemil Bilir
Medical Oncologist
Consultant
Graduation,MD
Istanbul, Turkey
20 years of experience
V M Medical Park, Pendik
Prof. Dr Zafer Gülbaş
Medical Oncologist
Professor
Graduation,Post Graduation
Istanbul, Turkey
43 years of experience
Anadolu Medical Center, Kocaeli, Istanbul
Spec. Dr. Mustafa Solak
Medical Oncologist
Senior Consultant
Istanbul, Turkey
15 years of experience
Hisar Hospital Intercontinental, Istanbul
Dr. M. Ali Kaplan
Medical Oncologist
Consultant
Post Graduation
Istanbul, Turkey
11 years of experience
Memorial Hospitals Group, İstanbul
Dr. Aysegul Kargi
Medical Oncologist
Consultant
Post Graduation
Istanbul, Turkey
10 years of experience
Memorial Hospitals Group, İstanbul
Dr. Alper Sonkaya
Medical Oncologist
Consultant
Istanbul, Turkey
13 years of experience
Acibadem Hospitals Group
Dr Necla Demir
Medical Oncologist
Consultant
Istanbul, Turkey
13 years of experience
Medicana International Istanbul
Dr Şerife Toptaş
Medical Oncologist
Consultant
Istanbul, Turkey
13 years of experience
Medicana International Istanbul
Prof. Serkan KESKİN
Medical Oncologist
Professor
Istanbul, Turkey
14 years of experience
Memorial Hospitals Group, İstanbul
DR.TAHSİN ÖZATLI
Medical Oncologist
Professor
Graduation,Post Graduation
Istanbul, Turkey
11 years of experience
İstinye Hospital, Bahçeşehir
Dr. Vildan Kayku
Medical Oncologist
Consultant
Graduation,Post Graduation
Istanbul, Turkey
9 years of experience
Medical Park Group, Istanbul
Dr. Emin Avşar
Medical Oncologist
Consultant
Graduation,Post Graduation
Istanbul, Turkey
9 years of experience
American Hospital, Istanbul
Dr. Hamida Akmurad Öztürk
Medical Oncologist
Consultant
Graduation,Post Graduation
Istanbul, Turkey
6 years of experience
American Hospital, Istanbul
Prof. Dr. Cemal Asim Kutlu
Medical Oncologist
Associate Professor
Graduation
Istanbul, Turkey
30 years of experience
Medical Park Goztepe Hospital
Dr. Merih Kalamanoglu Balci
Medical Oncologist
Consultant
Graduation,Post Graduation
Istanbul, Turkey
22 years of experience
